{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:14:57Z","timestamp":1777868097209,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00063-026-01432-7","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:59:40Z","timestamp":1775145580000},"page":"322-329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antikoagulation in der Intensivmedizin","Anticoagulation in critical care"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5308-0006","authenticated-orcid":false,"given":"Bernd","family":"P\u00f6tzsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah L.","family":"McRae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiko","family":"R\u00fchl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"1432_CR1","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/phar.2868","volume":"43","author":"WE Dager","year":"2023","unstructured":"Dager\u00a0WE, Trujillo\u00a0TC, Gilbert\u00a0BW (2023) Approaches to precision-based anticoagulation management in the critically ill. Pharmacotherapy 43:1221\u20131236","journal-title":"Pharmacotherapy"},{"key":"1432_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14383","volume":"55","author":"I Mah\u00e9","year":"2025","unstructured":"Mah\u00e9\u00a0I et\u00a0al (2025) Care pathway for patients hospitalized with venous thromboembolism. Eur J Clin Invest 55:e14383. https:\/\/doi.org\/10.1111\/eci.14383","journal-title":"Eur J Clin Invest"},{"key":"1432_CR3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1124\/pr.115.011247","volume":"68","author":"B Mulloy","year":"2016","unstructured":"Mulloy\u00a0B et\u00a0al (2016) Pharmacology of Heparin and Related Drugs. Pharmacol Rev 68:76\u2013141","journal-title":"Pharmacol Rev"},{"key":"1432_CR4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1517\/13543784.8.5.625","volume":"8","author":"W Jeske","year":"1999","unstructured":"Jeske\u00a0W et\u00a0al (1999) Pharmacology of argatroban. Expert Opin Investig Drugs 8:625\u2013654","journal-title":"Expert Opin Investig Drugs"},{"key":"1432_CR5","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1345\/aph.1D010","volume":"37","author":"WE Dager","year":"2003","unstructured":"Dager\u00a0WE, White\u00a0RH (2003) Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVH. Ann Pharmacother 37:1232\u20131236","journal-title":"Ann Pharmacother"},{"key":"1432_CR6","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1345\/aph.1Q177","volume":"45","author":"LV Tsu","year":"2011","unstructured":"Tsu\u00a0LV, Dager\u00a0WE (2011) Bivalirudin dosing adjustments for reduced renal function with or without hemodialysis in the management of heparin-induced thrombocytopenia. Ann Pharmacother 45:1185\u20131192","journal-title":"Ann Pharmacother"},{"key":"1432_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/cc4975","volume":"10","author":"M Levi","year":"2006","unstructured":"Levi\u00a0M, Opal\u00a0SM (2006) Coagulation abnormalities in critically ill patients. Crit Care 10:222\u2013231. https:\/\/doi.org\/10.1186\/cc4975","journal-title":"Crit Care"},{"key":"1432_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.thromres.2012.12.005","volume":"131","author":"DM Arnold","year":"2013","unstructured":"Arnold\u00a0DM (2013) Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness. Thromb Res 131:204\u2013209","journal-title":"Thromb Res"},{"key":"1432_CR9","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.3390\/jcm10225369","volume":"10","author":"FS Neuenfeldt","year":"2021","unstructured":"Neuenfeldt\u00a0FS, Weigand\u00a0MA, Fischer\u00a0D (2021) Coagulopathies in intensive care medicine: balancing act between thrombosis and bleeding. J\u00a0Clin Med 10:5369\u20135386","journal-title":"J Clin Med"},{"key":"1432_CR10","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1007\/s00701-023-05792-3","volume":"165","author":"Z Zhang","year":"2023","unstructured":"Zhang\u00a0Z, Cai\u00a0H, Vleggeert-Lankamp\u00a0CLA (2023) Thromboembolic prophylaxis in neurosurgical practice: a systematic review. Acta Neurochirurgica 165:3119\u20133135","journal-title":"Acta Neurochirurgica"},{"key":"1432_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/aas.70009","volume":"69","author":"\u00c8RH Heijkoop","year":"2025","unstructured":"Heijkoop \u00c8RH et\u00a0al (2025) Preferences for thromboprophylaxis in the intensive care unit: An international survey. Acta Anaesthesiol Scand 69:e70009. https:\/\/doi.org\/10.1111\/aas.70009","journal-title":"Acta Anaesthesiol Scand"},{"key":"1432_CR12","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1177\/0885066618796486","volume":"34","author":"TC Lewis","year":"2019","unstructured":"Lewis\u00a0TC et\u00a0al (2019) Venous thromboembolism prophylaxis: a narrative review with a focus on the high-risk critically ill patient. J\u00a0Intensive Care Med 34:877\u2013888","journal-title":"J Intensive Care Med"},{"key":"1432_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1053\/jcrc.2002.33941","volume":"17","author":"W Geerts","year":"2002","unstructured":"Geerts\u00a0W et\u00a0al (2002) Venous thromboembolism and its prevention in critical care. Journal of Critical Care 17:95\u2013104","journal-title":"Journal of Critical Care"},{"key":"1432_CR14","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.chest.2021.08.050","volume":"161","author":"SM Fernando","year":"2022","unstructured":"Fernando\u00a0SM et\u00a0al (2022) VTE prophylaxis in critically ill adults: a systematic review and network meta-analysis. Chest 161:418\u2013428","journal-title":"Chest"},{"key":"1432_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00134-022-06850-7","volume":"49","author":"J Helms","year":"2023","unstructured":"Helms\u00a0J, Middeldorp\u00a0S, Spyropoulos\u00a0AC (2023) Thromboprophylaxis in critical care. Intensive Care Med 49:75\u201378","journal-title":"Intensive Care Med"},{"key":"1432_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/EJA.0000000000000726","volume":"35","author":"A Afshari","year":"2018","unstructured":"Afshari\u00a0A et\u00a0al (2018) European guidelines on perioperative venous thromboembolism prophylaxis: mechanical prophylaxis. Eur J Anaesthesiol 35:112\u2013115","journal-title":"Eur J Anaesthesiol"},{"key":"1432_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/aas.13699","volume":"65","author":"AB Jonsson","year":"2021","unstructured":"Jonsson\u00a0AB et\u00a0al (2021) Thrombocytopenia in intensive care unit patients: a scoping review. Acta Anaesthesiol Scand 65:2\u201314","journal-title":"Acta Anaesthesiol Scand"},{"key":"1432_CR18","doi-asserted-by":"crossref","unstructured":"Douketis et\u00a0al. (2022) Executive summary: perioperative management of antithrombotic therapy: an American College of Chest Physicians clinical practice guideline. Chest 162:1127\u20131139","DOI":"10.1016\/j.chest.2022.08.004"},{"key":"1432_CR19","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/j.1875-9114.2011.01049.x","volume":"32","author":"JW Vandiver","year":"2012","unstructured":"Vandiver\u00a0JW, Vondracek\u00a0TG (2012) Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin. Pharmacotherapy 32:546\u2013558","journal-title":"Pharmacotherapy"},{"key":"1432_CR20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.7861\/clinmed2023-0076","volume":"23","author":"J Schofield","year":"2023","unstructured":"Schofield\u00a0J, Cheng-Hock\u00a0T (2023) How to approach acute thrombosis and thrombocytopenia. Clinical Medicine 23:234\u2013241","journal-title":"Clinical Medicine"},{"key":"1432_CR21","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa1816150","volume":"380","author":"YM Arabi","year":"2019","unstructured":"Arabi\u00a0YM et\u00a0al (2019) Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. N\u00a0Engl J Med 380:1305\u20131315","journal-title":"N Engl J Med"},{"key":"1432_CR22","first-page":"1","volume":"1","author":"A Greinacher","year":"2023","unstructured":"Greinacher\u00a0A, Warkentin\u00a0TE (2023) Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond. Hematology Am Soc Hematol Educ Program 1:1\u201310","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"1432_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00228-011-1149-6","volume":"68","author":"P Hoffmann","year":"2011","unstructured":"Hoffmann\u00a0P, Keller\u00a0F (2011) Increased major bleeding risk in patients with kidney dysfunction receiving enoxaparin: a\u00a0meta-analysis. Eur J Clin Pharmacol 68:757\u2013765","journal-title":"Eur J Clin Pharmacol"},{"key":"1432_CR24","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1160\/TH10-09-0614","volume":"105","author":"R Bauersachs","year":"2011","unstructured":"Bauersachs\u00a0R et\u00a0al (2011) CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiency. Thromb Haemost 105:981\u2013988","journal-title":"Thromb Haemost"},{"key":"1432_CR25","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1056\/NEJMra2104091","volume":"385","author":"JH Levy","year":"2021","unstructured":"Levy\u00a0JH, Connors\u00a0JM (2021) Heparin resistance \u2013 clinical perspectives and management strategies. N\u00a0Engl J Med 385:826\u2013832","journal-title":"N Engl J Med"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-026-01432-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00063-026-01432-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-026-01432-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:26:43Z","timestamp":1777548403000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00063-026-01432-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1432"],"URL":"https:\/\/doi.org\/10.1007\/s00063-026-01432-7","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"B.\u00a0P\u00f6tzsch\n                      : A.\u00a0Finanzielle Interessen: B.\u00a0P\u00f6tzsch gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B. Nichtfinanzielle Interessen: Universit\u00e4tsprofessor, stellvertretener Institutsdirektor, Institut f\u00fcr Experimentelle H\u00e4matologie und Transfusionsmedizin, Universit\u00e4tsklinikum Bonn.\n                      H.L.\u00a0McRae\n                      : A.\u00a0Finanzielle Interessen: Siemens Healthineers: Honorar als Referentin; BioTest, Sobi, Takeda: Kostenerstattung (Reise- und \u00dcbernachtungskosten) als Referentin; Sobi: Kostenerstattung (Reise- und \u00dcbernachtungskosten) als passive Teilnehmerin.\u00a0\u2013 B. Nichtfinanzielle Interessen: angestellte wissenschaftliche Mitarbeiterin\/Doktorandin \u2013\u00a0Institut f\u00fcr Experimentelle H\u00e4matologie und Transfusionsmedizin, Universit\u00e4tsklinikum Bonn.\n                      H.\u00a0R\u00fchl\n                      : A.\u00a0Finanzielle Interessen: Takeda, Sobi, Octapharma, Kedrion: Reisekosten und Teilnahmegeb\u00fchren.\u00a0\u2013 B. Nichtfinanzielle Interessen: \u00e4rztlicher Leiter der MVZ Venusberg GmbH, Bonn; gesch\u00e4ftsf\u00fchrender Oberarzt am Institut f\u00fcr Experimentelle H\u00e4matologie und Transfusionsmedizin, Universit\u00e4tsklinikum Bonn | Deutsche Gesellschaft f\u00fcr Transfusionsmedizin und Immunh\u00e4matologie, Mitglied und Obmann der Sektion H\u00e4mostaseologie | Mitgliedschaften: Gesellschaft f\u00fcr Thrombose- und H\u00e4mostaseforschung, American Society of Hematology, Deutsche Gesellschaft f\u00fcr Immungenetik, European Federation for Immunogenetics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}